Den Rozhnovsky / Shutterstock.com

18 February 2025NewsAmericasMarisa Woutersen

Apple voids Omni MedSci wearable tech patent

Patent Trial and Appeal Board rules all challenged claims were unpatentable | Decision follows Federal Circuit review that revived Apple’s challenge.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Whoop faces suit over tech in health tracker watch

6 February 2025 Popular fitness tracker device accused of infringing patents owned by Omni MedSci | Plaintiff previously sued Apple over Apple Watch.

Raising the pulse: How Masimo v Apple changed patent strategy

5 March 2024 The drama of the decade-long patent dispute reflects a changing market. Marisa Woutersen speaks with John Cronin and Pete Conley from Know Labs to explore its impact on patent strategy and the changing face of medtech.

More on this story

Whoop faces suit over tech in health tracker watch

6 February 2025 Popular fitness tracker device accused of infringing patents owned by Omni MedSci | Plaintiff previously sued Apple over Apple Watch.

Raising the pulse: How Masimo v Apple changed patent strategy

5 March 2024 The drama of the decade-long patent dispute reflects a changing market. Marisa Woutersen speaks with John Cronin and Pete Conley from Know Labs to explore its impact on patent strategy and the changing face of medtech.

More on this story

Whoop faces suit over tech in health tracker watch

6 February 2025 Popular fitness tracker device accused of infringing patents owned by Omni MedSci | Plaintiff previously sued Apple over Apple Watch.

Raising the pulse: How Masimo v Apple changed patent strategy

5 March 2024 The drama of the decade-long patent dispute reflects a changing market. Marisa Woutersen speaks with John Cronin and Pete Conley from Know Labs to explore its impact on patent strategy and the changing face of medtech.

More features

Patent cliff: 5 blockbusters running out of road

Herbert Smith Freehills expands German tech patent team

‘Always new twists’: Bayer legal team on defending a $4bn drug

Novartis and MSN feud intensifies after Fed Circ denies rehearing

EU court signals tough stance on ‘pay-for-delay’ pharma deals

Panitch Schwarze hires experienced ex-USPTO examiner

Fed Circ affirms generic’s litigation costs of $12m are tax-deductible

Genmab fights claim over 'secrets theft' behind $1.8bn takeover